Cian Healthcare Ltd

Cian Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Cian Healthcare Ltd

₹ 3.17 -1.55%
26 Aug - close price
cian.co BSE - SME: 542678
About

Incorporated in 2003, Cian Healthcare Ltd is engaged in manufacturing and marketing of pharmaceutical products.[1]

Key Points

Business Overview:[1][2]
CHI is a fully integrated pharmaceutical company dealing in gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.

Website BSE
  • Market Cap ₹ 7.92 Cr.
  • Current Price ₹ 3.17
  • High / Low ₹ 9.02 / 2.97
  • Stock P/E
  • Book Value ₹ 15.8
  • Dividend Yield 0.00 %
  • ROCE 5.22 %
  • ROE 0.43 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.20 times its book value
  • Company's working capital requirements have reduced from 35.1 days to 26.3 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 27.1%
  • Company has a low return on equity of -1.91% over last 3 years.
  • Promoters have pledged or encumbered 34.5% of their holding.
  • Promoter holding has decreased over last 3 years: -39.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
57.09 73.73 77.87 68.59 61.70
49.74 61.74 73.52 55.60 51.30
Operating Profit 7.35 11.99 4.35 12.99 10.40
OPM % 12.87% 16.26% 5.59% 18.94% 16.86%
0.79 0.07 0.47 0.73 1.12
Interest 7.22 7.92 6.55 6.30 6.00
Depreciation 4.45 3.45 4.27 5.43 5.47
Profit before tax -3.53 0.69 -6.00 1.99 0.05
Tax % 7.37% 91.30% -7.83% -2.01% -400.00%
-3.79 0.05 -5.53 2.03 0.25
EPS in Rs -1.62 0.02 -2.21 0.81 0.10
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -6%
TTM: 27%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 53%
TTM: -8600%
Stock Price CAGR
10 Years: %
5 Years: -27%
3 Years: -42%
1 Year: -67%
Return on Equity
10 Years: %
5 Years: %
3 Years: -2%
Last Year: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 23.36 23.36 25.00 25.00 25.00
Reserves 34.83 34.88 30.46 32.49 32.74
72.94 70.73 63.05 60.81 55.69
25.41 28.28 47.42 42.18 47.74
Total Liabilities 156.54 157.25 165.93 160.48 161.17
39.43 36.54 49.58 44.59 39.28
CWIP 25.03 25.93 13.00 13.89 14.70
Investments 4.89 4.89 4.89 4.89 4.89
87.19 89.89 98.46 97.11 102.30
Total Assets 156.54 157.25 165.93 160.48 161.17

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-7.31 5.93 8.58 4.84 11.76
-27.44 2.71 1.40 2.55 -1.46
35.78 -9.78 -10.96 -7.41 -10.44
Net Cash Flow 1.03 -1.13 -0.98 -0.01 -0.14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 127.80 93.56 125.24 139.58 121.15
Inventory Days 267.18 312.78 299.94 399.93 485.99
Days Payable 220.03 209.37 270.46 295.80 371.29
Cash Conversion Cycle 174.95 196.98 154.73 243.71 235.85
Working Capital Days 14.77 16.14 38.30 40.66 26.27
ROCE % 6.78% 0.50% 6.91% 5.22%

Shareholding Pattern

Numbers in percentages

3 Recently
Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025
70.89% 70.89% 66.26% 66.26% 66.26% 66.26% 51.85% 49.62% 27.10% 27.10% 27.11% 27.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
29.11% 29.11% 33.74% 33.74% 33.75% 32.96% 48.16% 50.39% 72.90% 72.90% 72.90% 72.89%
No. of Shareholders 3613853963924244184546728808311,0881,501

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings